Extendicare Inc. (TSE:EXE – Get Free Report) has been assigned a consensus rating of “Buy” from the seven research firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating, three have given a buy rating and three have given a strong buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is C$24.50.
A number of analysts recently commented on the company. National Bankshares lifted their price objective on Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Canadian Imperial Bank of Commerce lifted their price target on shares of Extendicare from C$18.00 to C$22.00 in a research report on Thursday, November 13th. Canaccord Genuity Group increased their price objective on shares of Extendicare from C$20.00 to C$22.50 in a report on Thursday, December 4th. TD Securities raised their price objective on shares of Extendicare from C$15.00 to C$19.00 in a research note on Thursday, November 13th. Finally, Cormark lifted their target price on shares of Extendicare from C$25.00 to C$30.00 in a report on Wednesday, December 3rd.
Get Our Latest Analysis on EXE
Extendicare Trading Down 1.0%
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
